The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model - Quiz - MDSpire

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

  • By

  • Zhang Lingyu

  • Feng Peng

  • Zhong Wanting

  • Jin Qianqian

  • Zijuan Zhang

  • Bo Bai

  • Guofang Xue

  • Christian Hölscher

  • May 5, 2026

  • 0 min

Share

Original Source(s)

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model

  • by Zhang Lingyu, Feng Peng, Zhong Wanting, Jin Qianqian, Zijuan Zhang, Bo Bai, Guofang Xue, Christian Hölscher

  • May 5, 2026

Related Content

AI-driven insights into protein misfolding and innate immunity in neurodegenerative diseases

Correction to: “Determinants of Pancreatic Size and Fat Content in the UK Biobank: Influence of Race, Genetic Variants, and Risk Factors”

  • February 9, 2026

Does Metabolic and Bariatric Surgery Reduce the Risk of Developing Parkinson’s Disease: A Propensity Score Matching Analysis Using Data from the National Inpatient Sample